Table 1.
Patients Characteristics | Non-ISR Group (15) |
ISR Group (40) |
p-Value |
---|---|---|---|
Age | 62 ± 2.73 | 66.5 ± 1.8 | 0.1844 |
Gender, N (%) | male 3 (20%) | male 8 (20%) | 1 |
female 12 (80%) | female 32 (80%) | 0.576 | |
Risk Factors, N (%) | |||
Smoking | 8 (53.3%) | 28 (70%) | 0.255 |
Hypertension | 11 (73.3%) | 30 (75%) | 0.902 |
Diabetes Mellitus | 6 (40%) | 25 (62.5%) | 0.139 |
Diabetes Type I | 3 (20%) | 9 (22.5%) | 0.845 |
Dyslipidemia | 12 (80%) | 28 (70%) | 0.547 |
Clinical Data, N (%) | |||
Angina Pectoris | 10 (66%) | 23 (57.5%) | 0.34 |
Acute Coronary Symptoms | 3 (20%) | 16 (40.0%) | 0.382 |
Chronic Kidney Disease | 1 (7%) | 0 (0%) | 0.103 |
Heart Failure | 1 (7%) | 1 (2.5%) | 0.471 |
Stent Details of the 1st PCI | |||
N° Stenosis | 26 | 70 | |
Affected Vessels: | |||
LAD | 21 (80.8%) | 45 (64.3%) | 0.47 |
LCX | 4 (15.4%) | 16 (22.8%) | 0.09 |
RCA * | 1 (3.8%) | 9 (12.9%) | 0.04 |
Stent Details of the 2nd PCI | |||
N° Stent Implanted | 58 | ||
Affected Vessels: | |||
LAD | 31 (53.4%) | ||
LCX | 18 (31.1%) | ||
RCA | 9 (15.5%) | ||
Treatments | |||
PCI | 36 (90%) | ||
CABG | 3 (7.5%) | ||
Pharmacologic Treatment | 1 (2.5%) |